Dergiler / Diagnostic and Interventional Radiology / 2021 / Cilt: 27 - Sayı: 2

Combined Y-configured stents for revising occluded transjugular intrahepatic portosystemic shunt

Sayfa
238–243
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The TIPS patency and survival rates were both 100% during a median follow-upperiod of 10 months (IQR, 5.5–14 months).CONCLUSIONTIPS revision by combined Y-configured stents placement was technically feasible and safewith favorable clinical outcomes.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:PURPOSEWe aimed to determine the technical feasibility, safety and prognosis of the transjugular intrahepatic portosystemic shunt (TIPS) revision by combined Y-configured stents placement.METHODSWe retrospectively evaluated 12 patients who received TIPS revision using Y-stenting technique between June 2015 and January 2019.
📊
Temel Bulgular & Veri:The rates of technical success, complication,shunt patency, hepatic encephalopathy and mortality were described and analyzed.RESULTSThe combined Y-configured stents were successfully placed in 11 of 12 patients (92%) without major complications.
💡
Sonuç & Katkı:The TIPS patency and survival rates were both 100% during a median follow-upperiod of 10 months (IQR, 5.5–14 months).CONCLUSIONTIPS revision by combined Y-configured stents placement was technically feasible and safewith favorable clinical outcomes.
🔬Tür:Araştırma Makalesi
📍Kapsam:2015 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

PURPOSEWe aimed to determine the technical feasibility, safety and prognosis of the transjugular intrahepatic portosystemic shunt (TIPS) revision by combined Y-configured stents placement.METHODSWe retrospectively evaluated 12 patients who received TIPS revision using Y-stenting technique between June 2015 and January 2019. The rates of technical success, complication,shunt patency, hepatic encephalopathy and mortality were described and analyzed.RESULTSThe combined Y-configured stents were successfully placed in 11 of 12 patients (92%) without major complications. The median portosystemic pressure gradient (PPG) decreased from23 mmHg (interquartile range, IQR, 18.5–27.5 mmHg) to 10 mmHg (IQR, 9–14 mmHg). The leftinternal jugular vein approach was used in 5 patients. Four patients required a shunt extension with an extra stent to resolve the stenosis at the portal venous terminus. Two patients developed hepatic encephalopathy, which was medically controlled within 3 months after theprocedure. The TIPS patency and survival rates were both 100% during a median follow-upperiod of 10 months (IQR, 5.5–14 months).CONCLUSIONTIPS revision by combined Y-configured stents placement was technically feasible and safewith favorable clinical outcomes.

🔖

Bu Makaleye Atıf Yap

WANG, X., ZHU, Y., ZHAO, M., LUO, X., YANG, L. (2021). Combined Y-configured stents for revising occluded transjugular intrahepatic portosystemic shunt. Diagnostic and Interventional Radiology, Cilt: 27 - Sayı: 2, 238–243. https://ajindex.com/articles/349957

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Boyer TD, Haskal ZJ. Role of transjugular intrahepatic portosystemic shunt (tips) in the management of portal hypertension: Update 2009. Hepatology 2010
  2. 306–306. [Crossref] 2. Weber CN, Nadolski GJ, White SB, et al. Longterm patency and clinical analysis of expanded polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunt stent grafts. J Vasc Interv Radiol 2015
  3. 1257–1265. [Crossref] 3. LaBerge JM, Ferrell LD, Ring EJ, Gordon RL. Histopathologic study of stenotic and occluded transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 1993
  4. 779–786. [Crossref] 4. Haskal ZJ. Improved patency of transjugular intrahepatic portosystemic shunts in humans: Creation and revision with ptfe stent-grafts. Radiology 1999
  5. 759–766. [Crossref] 5. Terayama N, Matsui O, Kadoya M, et al. Transjugular intrahepatic portosystemic shunt: Histologic and immunohistochemical study of autopsy cases. Cardiovasc Intervent Radiol 1997
  6. 457– 461. [Crossref] 6. Luo XF, Zhao M, Wang XZ, et al. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft. PloS one 2019
  7. e0212658. [Crossref] 7. Tanaka T, Gunther RW, Isfort P, Kichikawa K, Mahnken AH. Pull-through technique for recanalization of occluded portosystemic shunts (tips): Technical note and review of the literature. Cardiovasc Intervent Radiol 2011
  8. 406– 412. [Crossref] 8. Chan CY, Liang PC. Recanalization of an occluded intrahepatic portosystemic covered stent via the percutaneous transhepatic approach. Korean J Radiol 2010
  9. 469–471. [Crossref] 9. Pereira K, Baker R, Salsamendi J, Doshi M, Kably I, Bhatia S. An approach to endovascular and percutaneous management of transjugular intrahepatic portosystemic shunt (tips) dysfunction: A pictorial essay and clinical practice algorithm. Cardiovasc Intervent Radiol 2016
  10. 639–651. [Crossref] 10. Luo XF, Nie L, Tsauo JW, Wang Z, Tang CW, Li X. Parallel shunt for the treatment of transjugular intrahepatic portosystemic shunt dysfunction. Korean J Radiol 2013
  11. 423–429. [Crossref] 11. Raissi D, Yu Q, Nisiewicz M, Krohmer S. Parallel transjugular intrahepatic portosystemic shunt with viatorr(®) stents for primary tips insufficiency: Case series and review of literature. World J Hepatol 2019
  12. 217–225. [Crossref] 12. Gwon DI, Ko GY, Yoon HK, et al. Safety and efficacy of percutaneous y-configured covered stent placement for malignant hilar b